304 related articles for article (PubMed ID: 8689655)
1. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
Linck B; Bokník P; Eschenhagen T; Müller FU; Neumann J; Nose M; Jones LR; Schmitz W; Scholz H
Cardiovasc Res; 1996 Apr; 31(4):625-32. PubMed ID: 8689655
[TBL] [Abstract][Full Text] [Related]
2. Reduced sarcoplasmic reticulum Ca(2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure.
Gupta RC; Mishra S; Mishima T; Goldstein S; Sabbah HN
J Mol Cell Cardiol; 1999 Jul; 31(7):1381-9. PubMed ID: 10403755
[TBL] [Abstract][Full Text] [Related]
3. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
[TBL] [Abstract][Full Text] [Related]
5. Reduced sarcoplasmic reticulum Ca2+ uptake and increased Na+-Ca2+ exchanger expression in left ventricle myocardium of dogs with progression of heart failure.
Mishra S; Sabbah HN; Rastogi S; Imai M; Gupta RC
Heart Vessels; 2005 Feb; 20(1):23-32. PubMed ID: 15700199
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure.
DiPaola NR; Sweet WE; Stull LB; Francis GS; Schomisch Moravec C
J Mol Cell Cardiol; 2001 Jun; 33(6):1283-95. PubMed ID: 11444930
[TBL] [Abstract][Full Text] [Related]
7. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
8. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.
Linck B; Bokník P; Baba HA; Eschenhagen T; Haverkamp U; Jäckel E; Jones LR; Kirchhefer U; Knapp J; Läer S; Müller FU; Schmitz W; Scholz H; Syska A; Vahlensieck U; Neumann J
J Pharmacol Exp Ther; 1998 Jul; 286(1):531-8. PubMed ID: 9655899
[TBL] [Abstract][Full Text] [Related]
9. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.
Mercadier JJ; Lompré AM; Duc P; Boheler KR; Fraysse JB; Wisnewsky C; Allen PD; Komajda M; Schwartz K
J Clin Invest; 1990 Jan; 85(1):305-9. PubMed ID: 2136864
[TBL] [Abstract][Full Text] [Related]
10. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.
Sande JB; Sjaastad I; Hoen IB; Bøkenes J; Tønnessen T; Holt E; Lunde PK; Christensen G
Cardiovasc Res; 2002 Feb; 53(2):382-91. PubMed ID: 11827689
[TBL] [Abstract][Full Text] [Related]
11. Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.
Lüss I; Boknik P; Jones LR; Kirchhefer U; Knapp J; Linck B; Lüss H; Meissner A; Müller FU; Schmitz W; Vahlensieck U; Neumann J
J Mol Cell Cardiol; 1999 Jun; 31(6):1299-314. PubMed ID: 10371704
[TBL] [Abstract][Full Text] [Related]
12. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.
Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P
J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism underlying calcium handling in diastolic heart failure].
Zhong M; Zhang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):669-72. PubMed ID: 11798946
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression.
Kimura Y; Otsu K; Nishida K; Kuzuya T; Tada M
J Mol Cell Cardiol; 1994 Sep; 26(9):1145-54. PubMed ID: 7815458
[TBL] [Abstract][Full Text] [Related]
15. cAMP-dependent protein kinase A-stimulated sarcoplasmic reticulum function in heart failure.
Schwinger RH; Bölck B; Münch G; Brixius K; Müller-Ehmsen J; Erdmann E
Ann N Y Acad Sci; 1998 Sep; 853():240-50. PubMed ID: 10603952
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of phospholamban by cAMP-dependent protein kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes.
Negash S; Chen LT; Bigelow DJ; Squier TC
Biochemistry; 1996 Sep; 35(35):11247-59. PubMed ID: 8784178
[TBL] [Abstract][Full Text] [Related]
17. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
[TBL] [Abstract][Full Text] [Related]
18. Cyclic stretch down-regulates calcium transporter gene expression in neonatal rat ventricular myocytes.
Cadre BM; Qi M; Eble DM; Shannon TR; Bers DM; Samarel AM
J Mol Cell Cardiol; 1998 Nov; 30(11):2247-59. PubMed ID: 9925362
[TBL] [Abstract][Full Text] [Related]
19. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium.
Movsesian MA; Karimi M; Green K; Jones LR
Circulation; 1994 Aug; 90(2):653-7. PubMed ID: 8044934
[TBL] [Abstract][Full Text] [Related]
20. The expression of SR calcium transport ATPase and the Na(+)/Ca(2+)Exchanger are antithetically regulated during mouse cardiac development and in Hypo/hyperthyroidism.
Reed TD; Babu GJ; Ji Y; Zilberman A; Ver Heyen M; Wuytack F; Periasamy M
J Mol Cell Cardiol; 2000 Mar; 32(3):453-64. PubMed ID: 10731444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
